Soluble KIT correlates with clinical outcome in patients with metastatic breast cancer treated with sunitinib

by Keyvanjah Kiana, DePrimo Samuel E, Harmon Charles S, Huang Xin, Kern Kenneth A, Carley William
Published 2012-08-01

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

by Spinella Dominic, Baum Charles M, Smeraglia John, Bello Carlo L, DePrimo Samuel E, Rini Brian I, Michaelson M Dror, Motzer Robert J
Published 2007-07-01

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification

by Smolich Beverly D, Manning William C, Nicholas Susan L, Khatry Deepak B, Wong Lily M, DePrimo Samuel E, O'Farrell Anne-Marie, Cherrington Julie M
Published 2003-02-01

Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib

by Lim Ho Y, Douillard Jean-Yves, Boucher Eveline, Cheng Ann-Lii, Raymond Eric, DePrimo Samuel E, Harmon Charles S, Kim Jun S, Lechuga Maria, Lanzalone Silvana, Lin Xun, Faivre Sandrine
Published 2011-07-01